HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunscreen Rule Will Cost Four Times FDA’s Prediction, Industry Tells OMB

This article was originally published in The Tan Sheet

Executive Summary

FDA's low-ball estimate of the cost to industry from the final OTC sunscreen monograph – a quarter of the amount manufacturers anticipate – relieved the agency from having to submit a full account of its rulemaking to the Office of Management and Budget, Energizer Holdings suggests.

You may also be interested in...



Industry Groups Shine Light On “Helps Prevent” Claim In Sunscreen Comments

Sunscreen labeling that claims the product "helps prevent" premature skin aging, cancer and other damage does not suggest sunscreen alone protects against these conditions, but in fact informs consumers that "complementary measures" are needed for adequate protection, according to trade groups' comments on FDA's proposal to amend the sunscreen final monograph

PCPC Sees Opportunity For US Cosmetics Modernization After Congressional Mid-Terms

The Personal Care Products Council is pivoting to focus on passing cosmetics modernization legislation after mid-term congressional elections, while still hopeful the language could go through as part of FDA user-fee reauthorization. Karin Ross, executive VP, government affairs at PCPC, discussed the situation at the trade group’s Leadership Summit in Washington.

Estee Lauder Companies Signals Growing Luxury Appetite, Possible M&A On Horizon

ELC’s Guillaume Jesel has been named president of global brands overseeing Tom Ford Beauty and Balmain Beauty, the latter targeted for launch in fall 2024 under a licensing agreement with the French fashion house announced on 26 September. Jesel also will head up luxury business development with a “key role in prospective acquisitions and investment strategy.”

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS134709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel